Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
3/30/2022 - COVID-19 BA.2 Subvariant & Boosters
Manage episode 324232432 series 2065653
Dr. Paul Auwaerter discusses the BA.2 Subvariant and the recent authorization from the FDA for second booster dose. Topics: *Virulence of BA.2 vs Omicron and Delta * Therapeutic activity of monoclonal antibodies against BA.2 *Details of approval for booster #2 (4th and 5th dose) *Are there advantages to mixing mRNA vaccines?
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-30-22-episode/eval
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty
Presenting faculty:
Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine
Hosted on Acast. See acast.com/privacy for more information.
207 tập
Manage episode 324232432 series 2065653
Dr. Paul Auwaerter discusses the BA.2 Subvariant and the recent authorization from the FDA for second booster dose. Topics: *Virulence of BA.2 vs Omicron and Delta * Therapeutic activity of monoclonal antibodies against BA.2 *Details of approval for booster #2 (4th and 5th dose) *Are there advantages to mixing mRNA vaccines?
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/3-30-22-episode/eval
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty
Presenting faculty:
Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine
Hosted on Acast. See acast.com/privacy for more information.
207 tập
Tất cả các tập
×Chào mừng bạn đến với Player FM!
Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.